Precautions and Warnings With Ipratropium and Albuterol Inhaler

There are many important precautions and warnings with ipratropium and albuterol inhaler to be aware of prior to taking the medication. Among these are the possibility that the medication can worsen breathing problems, glaucoma, and bladder problems. Precautions and warnings with ipratropium and albuterol inhaler also apply to people who are allergic to soybeans, peanuts, or soy lecithin.

The Ipratropium and Albuterol Inhaler: What Should I Tell My Healthcare Provider?

In order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer, Combivent inhalers (in their original form) will not be available after July 2013 because they contain chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. A new formulation, Combivent Respimat, became available starting in October 2012. People using the old Combivent inhaler will need to get a new prescription in order to switch to the new Combivent Respimat inhaler.

 

You should talk with your healthcare provider prior to taking the ipratropium and albuterol inhaler (Combivent®) if you have:
 
Also, let your healthcare provider know if you are:
 
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
     
Make sure to tell your healthcare provider about all of the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.
 

Information on Ipratropium and Albuterol

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.